; (B) patterns, trends, and variations in the duration of shortages experienced by covered part D drugs; (C) patterns, trends, and variations in the proximate causes and other potential causes of shortages experienced by covered part D drugs; (D) effects of such shortages on beneficiaries enrolled in prescription drug plans under this part, including with respect to access to covered part D drugs and out-of-pocket costs